India's Pharmaceutical Exports

Country Profile

Bangladesh

Bangladesh is a major destination for Indian pharmaceutical exports — $302M in FY 2025–26, with 2.3× growth over the past decade. Medicine Ingredients accounts for 57% of shipments, with vaccines contributing $67.5M. The compound annual growth rate since FY2015 stands at 8.1%.

🇧🇩 #24 Destination · $302M · 2.3× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$302M
Exports FY2025–26 DGCIS
2.3×
Growth FY2015→2026
1.0%
Share of India Total
#24
Rank Among 178 Markets
8.1%
CAGR FY2015→2026
Bangladesh is a major destination for Indian pharmaceutical exports — $302M in FY 2025–26, with 2.3× growth over the past decade. Medicine Ingredients accounts for 57% of shipments, with vaccines contributing $67.5M. The compound annual growth rate since FY2015 stands at 8.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $172M (57.1%) Vaccines $67.5M (22.4%) Medicines $36.0M (11.9%) Surgical & Hospital Supplies $15.3M (5.1%) Traditional & Herbal $10.6M (3.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bangladesh in the RBI overseas direct investment dataset (2011–2026).